Products, services, reviews and techniques used in the identification and validation of the disease-causing target genes and proteins.
Sartobind® Rapid A is provided as ready-to-use devices which will be fully utilized within a single batch and afterwards disposed: >150 g/L*h productivity, >30 g/L DBC 10% at 12 sec RT, Average cycle times of only 10-15 min.
Flexel® 3D single-use bags for Palletank® are designed for the processing and storage of large volumes of biopharmaceuticals fluids in Palletank® containers. They are available in a range of sizes from 50 L to 1000 L (custom sizes available upon request).
The Palletank ® for shipping was specifically developed for the secure and convenient shipment of bulk pharmaceutical fluids. It is available in volumes of 100L, 200L, and 500L. The associated shipping kit must be purchased along with the Palletank ® container for the system to be complete.
Flexel® Bags for Magnetic Mixer provide a fast dissolution of media powders and an efficient mixing of high concentration buffers or viscous products.
LiquidPlex panel is an advanced and user-friendly research assay for targeted next generation sequencing of circulating cell-free tumor DNA (ccfDNA/cfDNA/ctDNA) from 28 genes commonly associated with solid tumor type cancers.
FusionPlex Lung v2 is a research assay for targeted next generation sequencing of RNA for characterization of variants, indels, and fusions, including novel fusions, from 17 genes associated with NSCLC.
FusionPlex Core Solid Tumor is a research assay for targeted next generation sequencing of RNA for characterization of variants, indels, and fusions, including novel fusions, from 57 genes associated with various solid tumor malignancies.
FusionPlex Core Solid Tumor is a research assay for targeted next generation sequencing of RNA for characterization of variants, indels, and fusions, including novel fusions, from 57 genes associated with various solid tumor malignancies.
FusionPlex Pan Solid V2 is a research assay for targeted next generation sequencing of RNA for characterization of variants, indels, and fusions, including novel fusions, from 137 genes associated with various solid tumor malignancies.
VariantPlex Solid Tumor Focus V2 is a research assay for targeted next generation sequencing of DNA for characterization of SNVs, indels, CNVs, and MSI from 20 genes associated with various solid tumor malignancies.
VariantPlex Core Solid Tumor is a research assay for targeted next generation sequencing of DNA for characterization of SNVs, indels, CNVs, and MSI from 60 genes associated with various solid tumor malignancies.
VariantPlex Expanded Solid Tumor is a research assay for targeted next generation sequencing of DNA for characterization of SNVs, indels, CNVs, and MSI from 76 genes associated with various solid tumor malignancies.
VariantPlex Pan Solid Tumor is a research assay for targeted next generation sequencing of DNA for characterization of SNVs, indels, CNVs, MSI, and TMB from 185 genes associated with various solid tumor malignancies.
VariantPlex Complete Solid Tumor is a research assay for targeted next generation sequencing of DNA for characterization of SNVs, indels, CNVs, MSI, and TMB from 430 genes associated with various solid tumor malignancies.
Immunoverse is a research assay that characterizes the immune repertoire, including assessment of T- and B-cell clonalities and rare clones, and detection of tumor infiltrating lymphocytes (TIL) and somatic hypermutation with targeted NGS of key T cell receptor and B cell receptor chain RNA relevant for blood cancer and solid tumor research.
VariantPlex Myeloid is a research assay for targeted next generation sequencing of DNA for characterization of SNVs, indels, CNVs, and ITDs from 75 genes associated with acute myeloid leukemia (AML), myeloproliferative neoplasms (MPN), myelodysplastic syndromes (MDS).
VariantPlex Core Myeloid is a research assay for targeted next generation sequencing of DNA for characterization of SNVs, indels, CNVs, and ITDs from 37 genes associated with acute myeloid leukemia (AML), myeloproliferative neoplasms (MPN), myelodysplastic syndromes (MDS).
FusionPlex Pan Heme is a research assay for targeted next generation sequencing of RNA for characterization of variants, indels, expression, and fusions, including novel fusions, from 199 genes associated with lymphoid and myeloid malignancies.
FusionPlex Heme V2 is a research assay for targeted next generation sequencing of RNA for characterization of variants, indels, expression, and fusions, including novel fusions, from 87 genes associated with lymphoid and myeloid malignancies.
FusionPlex Myeloid is a research assay for targeted next generation sequencing of RNA for characterization of variants, indels, expression, and fusions, including novel fusions, from 84 genes associated with myeloid-origin malignancies.
FusionPlex Lymphoma is a research assay for targeted next generation sequencing of RNA for characterization of variants, indels, expression, and fusions, including novel fusions, from 125 genes associated with lymphomas.
FusionPlex ALL is a research assay for targeted next generation sequencing of RNA for characterization of variants, indels, expression, and fusions, including novel fusions, from 81 genes associated with acute lymphoblastic leukemia (ALL) .
Accumax Erlenmeyer Flask- the perfect solution for suspension culture of mammalian cells, plants, microbes and microorganisms. These flasks are not only ideal for containing, mixing and storing solutions, but also offer a safer alternative to glass. With their durable construction, they won't break, chip or shatter during the hustle and bustle of everyday lab work.
Phase Separator is a unique, new pipetting capability on the Fluent® Automation Workstation. This patented liquid separation technology can detect liquid-liquid interfaces and effectively separate neighbor phases while avoiding contamination. Suitable for removing the plasma phase from a centrifuged blood sample, it delivers up to double the speed of camera-based systems for plasma separation.
As the framework of stellar automation, Nucleus® Automation Infrastructure combines (A) your choice of stationary or mobile mounted collaborative robotic arms; (B) mobile cart or stationary table work surfaces to house your preferred devices; and (C) powerful Cellario™ Whole Lab Automation software. Unique MicroDock technology lets you effortlessly roll workflow devices in and out for space efficiency and manual device use.
